Holmusk and Otsuka team up to develop real-world evidence based behavioural health platform.
| CONTEXT: Commercial announcement that Holmusk and Otsuka are partnering to develop one of the largest real-world evidence behavioural health platforms in the world. Gaining a better understanding of behavioural health (essentially the connection between our behaviour and the impact on our health, like eating and drinking habits, exercise and addictive behaviour patterns) is extremely important in moving forward research into a wide variety of health conditions including oncology, renal, cardiovascular and mental health. According to the statement from Otsuka, it is hoped the this collaboration will bolster Otsuka’s abilities to cater for the unmet clinical needs of people living with complicated and chronic diseases. READ TIME: 2 mins  1. “Holmusk, Inc. is focused on developing digital solutions to accelerate research, innovation, and care on behavioral health. ” 2. “Otsuka Pharmaceutical Development and Commercialization Inc. , which is a part of the Otsuka Pharmaceuticals, announced a three-year partnership with digital health company, Holmusk, Inc. to develop one of the largest real-world evidence platform for behavioral health in the world. ” 3. “The collaboration deal is valued around USD 4 million annually and follows Holmusk’s recent acquisition of the U. K-based Otsuka Health Solutions. ” 4. “It leverages proprietary analytics along with Natural Language processing and disease models developed by predictive analytics to refine behavior health data. ” 5. “Under the collaboration, Holmusk and Otsuka will together work to bolster the understanding of the unmet clinical demands and real-world outcomes by utilizing analytics and artificial intelligence (AI) on various real-time data sources. ” Source URL: https://investorwelcome.com/2021/07/09/otsuka-collaborates-with-digital-health-company-holmusk-inc-to-enhance-data-analytics-and-ai-for-behavior-health-programs/ |